Educational

  1. April 18, 2024

    Podcast: Clearing the air on compounding GLP1 drugs

    The whole issue of compounding GLP-1 agonists like semaglutide is fraught with land mines and misinformation — disinformation, even.

    It's good, then, that the Game Changers Pharmacotherapy Podcast had a couple of guests who know what they're talking about to clear some of the air: Tenille Davis, PharmD, RPh (chief advocacy officer for the Alliance for Pharmacy Compounding) and Scott Brunner, CAE (CEO of APC). The host — Geoff Wall, PharmD — has the chops, too; he's a professor of pharmacy practice at Drake University.

    It covers everything you need to know about compounding GLP-1s, including access, cost, and how shortages come into play. Even better, you might be able to get a half-hour of CPE credit, too!

    Check out "Compounded GLP1s" on the Game Changers podcast — click here or check your favorite podcast app.

    Read More
  2. February 27, 2024

    A Guide to Writing a Compounded Prescription for Hormone Replacement Therapy (HRT)

    Zoom-header2

    Hormone Replacement Therapy (HRT) is a treatment option widely prescribed for patients experiencing various symptoms related to hormonal imbalances. Compounded prescriptions for HRT allow healthcare practitioners to tailor medications specific to individual patient’s needs, providing a more personalized approach to therapy. This blog will guide practitioners through writing a compounded prescription for Hormone Replacement Therapy to ensure optimal patient care and treatment outcomes.

    1. Patient Assessment

    Before writing a compounded prescription for HRT, it is critical to conduct

    Read More
  3. November 01, 2023

    Important USP changes — what you need to know

    Some important updates regarding quality standards and changes to the United States Pharmacopeia (USP) standards are coming that may impact your practice.

    To give some background, pharmacies in the Revelation Pharma Network follow standard operating procedures that are built around processes developed by USP. While USP is not a regulatory agency and does not carry the force of law, many state boards of pharmacy as well as the FDA recognize USP’s compounding standards as the measure of quality assurance that a compounding pharmacy should follow.

    On November 1, 2023, new editions of USP chapters pertaining to nonsterile, sterile, and hazardous drug compounding will become compendially applicable, meaning that they are the most current versions and regulatory agencies may choose to adopt them.

    It is important to note that these new editions are not simple modifications but are largely complete re-writes of the current chapters and represent significant

    Read More
  4. October 04, 2023

    Three threats that may impede patient access to compounded medications

    If you prescribe compounded medications, you’ll want to be aware of current threats to patient access to those drugs. Here’s the skinny – and what you can do to push back against regulatory overreach, bad science, and general misinformation about compounded therapies.

     

    Compounded hormones: The threat continues

    Since announcing in 2020 that it would base its next steps on compounded hormones in part on a

    Read More